Literature DB >> 2797819

High frequency of APC loss in sporadic colorectal carcinoma due to breaks clustered in 5q21-22.

P G Ashton-Rickardt1, M G Dunlop, Y Nakamura, R G Morris, C A Purdie, C M Steel, H J Evans, C C Bird, A H Wyllie.   

Abstract

Familial adenomatous polyposis is transmitted by a gene (APC) located within 5q21-22. Hemizygous loss of at least a part of 5q has been reported in 19-36% of sporadic colorectal carcinomas. This suggests that an anti-oncogene is located on that chromosome arm, but the probes used previously gave little information on the status of APC in the tumours. Using DNA probes homologous to polymorphic sequences flanking and close to the APC locus we show that more than half of a large series of carcinomas had lost at least one flanking allele. Mapping of allele losses provides data that imply clustering of breakpoints in a 10-15 megabase region around APC. The commonest chromosome defect responsible for APC loss was interstitial deletion. Mitotic recombination or partial arm loss were less frequent mechanisms. Whole chromosome loss was rare. This pattern contrasts with that reported in acquired homozygosity at other anti-oncogene loci in sporadic tumours and implies that APC loss is an early event in colorectal carcinogenesis. This view is also supported by the observations that 5q21-22 loss occurs with similar frequency in DNA diploid and DNA aneuploid tumours, and also in tumours at all clinical stages of progression.

Entities:  

Mesh:

Year:  1989        PMID: 2797819

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  33 in total

1.  Germ-line mutations of the APC gene in 53 familial adenomatous polyposis patients.

Authors:  Y Miyoshi; H Ando; H Nagase; I Nishisho; A Horii; Y Miki; T Mori; J Utsunomiya; S Baba; G Petersen
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-15       Impact factor: 11.205

2.  Familial colorectal cancer: discussion paper.

Authors:  M J Underwood; V W Johnson
Journal:  J R Soc Med       Date:  1992-06       Impact factor: 5.344

Review 3.  Two hits revisited again.

Authors:  I P Tomlinson; R Roylance; R S Houlston
Journal:  J Med Genet       Date:  2001-02       Impact factor: 6.318

4.  Molecular nature of chromosome 5q loss in colorectal tumors and desmoids from patients with familial adenomatous polyposis.

Authors:  M Okamoto; C Sato; Y Kohno; T Mori; T Iwama; A Tonomura; Y Miki; J Utsunomiya; Y Nakamura; R White
Journal:  Hum Genet       Date:  1990-10       Impact factor: 4.132

Review 5.  Molecular cloning of BRCA1: a gene for early onset familial breast and ovarian cancer.

Authors:  A M Bowcock
Journal:  Breast Cancer Res Treat       Date:  1993-11       Impact factor: 4.872

6.  Refinement of heterozygosity loss on chromosome 5p15 in sporadic colorectal cancer.

Authors:  Shi-Feng Xu; Zhi-Hai Peng; Da-Peng Li; Guo-Qiang Qiu; Fang Zhang
Journal:  World J Gastroenterol       Date:  2003-08       Impact factor: 5.742

7.  Linkage analysis in adenomatous polyposis coli: the use of four closely linked DNA probes in 20 UK families.

Authors:  M B Cachon-Gonzalez; J D Delhanty; J Burn; K Tsioupra; M B Davis; J Attwood; P Chapman
Journal:  J Med Genet       Date:  1991-10       Impact factor: 6.318

Review 8.  Role of the Wnt-Frizzled system in cardiac pathophysiology: a rapidly developing, poorly understood area with enormous potential.

Authors:  Kristin Dawson; Mona Aflaki; Stanley Nattel
Journal:  J Physiol       Date:  2012-12-03       Impact factor: 5.182

Review 9.  Guanylyl cyclase C in colorectal cancer: susceptibility gene and potential therapeutic target.

Authors:  Jieru E Lin; Peng Li; Giovanni M Pitari; Stephanie Schulz; Scott A Waldman
Journal:  Future Oncol       Date:  2009-05       Impact factor: 3.404

10.  Prognostic significance of the allelic loss of the BRCA1 gene in colorectal cancer.

Authors:  J M Garcia; R Rodriguez; G Dominguez; J M Silva; M Provencio; J Silva; A Colmenarejo; I Millan; C Muñoz; C Salas; S Coca; P España; F Bonilla
Journal:  Gut       Date:  2003-12       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.